CME webinar: Hepatitis C, B, and HIV: Screening and Management
Mar. 2024Education/Webinars
Please join us for a live, continuing medical education (CME)-accredited webinar on Wednesday, May 1, from noon to 1 p.m. The webinar will provide an overview of hepatitis C, B, and HIV screening and management. During this presentation, our expert will:
Presenter:
Nicholas DeGregorio, MD, MMM, FACP,
Associate Vice President, Medicaid Medical Services, UPMC Health Plan
Register now.
This webinar will be recorded.
This activity is approved for AMA PRA Category 1 Credit™ and ANCC. Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.
This activity has been designated as and meets the Pennsylvania licensure requirement for Patient Safety-Risk Management Credit. It is the responsibility of the learner to maintain the educational presentation or conference agenda as evidence, if needed for audit purposes.
Provider is responsible for verifying CME eligibility.
- Review the prevalence, trends, and screening recommendations for hepatitis B, C, and HIV.
- Discuss recommended screening tests and the interpretation of the results.
- Review the management of hepatitis C and the role of primary care in its treatment.
- Discuss considerations with hepatitis C, B, and HIV coinfections.
Presenter:
Nicholas DeGregorio, MD, MMM, FACP,
Associate Vice President, Medicaid Medical Services, UPMC Health Plan
Register now.
This webinar will be recorded.
This activity is approved for AMA PRA Category 1 Credit™ and ANCC. Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.
This activity has been designated as and meets the Pennsylvania licensure requirement for Patient Safety-Risk Management Credit. It is the responsibility of the learner to maintain the educational presentation or conference agenda as evidence, if needed for audit purposes.
Provider is responsible for verifying CME eligibility.
Recent Announcements
Voluntary nationwide recall: Cyclobenzaprine (Unichem – August 2025)
Unichem Pharmaceuticals (USA), Inc. is recalling one lot, lot GMML24026A, of Cyclobenzaprine Hydrochloride Tablets USP 10 mg. Cyclobenzaprine is used for the relief of muscle spasms from certain conditions.Sep. 2025Pharmacy Updates
Voluntary nationwide recall: Lactated Ringers and 0.9% Sodium Chloride (B. Braun-Aug)
B. Braun Medical, Inc. is recalling two lots of Lactated Ringers Injection USP 1000 mL and 0.9% Sodium Chloride Injection USP 1000 mL. These are intravenous (IV) fluids commonly used in the hospital to treat dehydration and other conditions.Aug. 2025Pharmacy Updates
CME Webinar: Evaluating Antimicrobial Stewardship Techniques in the Outpatient Setting
Please join us for a live, CME-accredited webinar on Tuesday, Nov. 4, from noon to 1 p.m. that will share an overview of evaluating antimicrobial stewardship techniques in the outpatient setting.Aug. 2025Education/Webinars